Archives
-
GI Delivery of mRNA-LNPs in Mice and Pigs
2026-09-21
This study evaluates an ingestible microjet device for delivering mRNA-loaded lipid nanoparticles into the stomach and intestinal walls of mice and minipigs. Its central finding is that gastrointestinal administration produces route-dependent expression and biodistribution, including detectable mRNA in plasma and lymph nodes, while preserving nanoparticle function after jetting.
-
TMEM16F, Ferroptosis, and Tumor Immune Rejection
2026-09-21
Yang and colleagues identify TMEM16F-mediated plasma-membrane lipid scrambling as an execution-phase suppressor of ferroptosis. Their study connects membrane tension, ferroptotic lysis, danger-signal release, and response to PD-1 blockade, suggesting that lipid remodeling can influence both cancer-cell death and antitumor immunity.
-
3-Aminobenzamide: From PARP Biology to Translation
2026-09-20
A translational framework for using 3-Aminobenzamide (PARP-IN-1) to connect PARP biology with oxidative stress, vascular dysfunction, diabetic nephropathy research, and carefully bounded antiviral questions.
-
Zika Virus Phosphoproteome Maps Host Control
2026-09-19
This study provides a global map of host-driven post-translational modifications on Zika virus proteins and identifies envelope phosphosites that regulate particle release and cytopathogenicity. Its combination of mass spectrometry, kinase-interaction analysis, and functional testing also links bosutinib-sensitive host kinase activity to viral growth, offering a framework for studying host regulation of flavivirus biology.
-
Recombinant Human Oncostatin M: Assay Workflows
2026-09-18
Build reproducible cytokine-response assays with a tag-free, E. coli-expressed OSM reagent designed for controlled stimulation, potency benchmarking, and translational model development. Practical guidance covers fibroblast, smooth muscle, endothelial, tumor-cell, and exploratory neuroinflammation workflows.
-
Rosiglitazone (Brl-49653) Workflow Guide
2026-09-18
Build reproducible adipocyte and metabolic assays with Rosiglitazone, using controlled PPARγ activation alongside transcriptional, lipid, and mitochondrial readouts. This guide also translates recent SEMA3E–β-catenin findings into practical comparison experiments for adipogenesis and thermogenesis research.
-
3-Aminobenzamide: A Strategic PARP Research Tool
2026-09-17
3-Aminobenzamide (PARP-IN-1) is best positioned as a mechanistic PARP research probe for oxidative stress, vascular biology, diabetic nephropathy research, and carefully controlled innate-immunity studies. This article connects product evidence with coronavirus PARP biology while defining the translational boundaries that researchers should respect.
-
Nicotine Signaling and CKD Progression: Study Insights
2026-09-17
Jain and Jaimes interpret nicotine as more than an addictive constituent of tobacco, highlighting its direct effects on renal nicotinic acetylcholine receptors, reactive oxygen species, hemodynamics, and fibrosis. Their review integrates clinical observations with animal models to explain how nicotine may accelerate chronic kidney disease and to identify testable targets for future mechanistic studies.
-
E-4031 as a 3D Electrophysiology Stress Test
2026-09-16
E-4031 is a potent hERG potassium channel blocker for cardiac electrophysiology research. This article explains how shell microelectrode arrays convert its repolarization effects into spatially resolved evidence for QT interval prolongation, torsades de pointes (TdP) induction, and proarrhythmic substrate modeling.
-
Fluorescein Tyramide for Oxytocin Circuit Assays
2026-09-16
Fluorescein Tyramide enables sensitive spatial validation of oxytocin signaling in neural tissue. This article translates recent early-life-adversity findings into practical choices for IHC, ISH, and flow cytometry assay design, with emphasis on controls and interpretability.
-
Axitinib (AG 013736) Assay Workflow Guide
2026-09-15
Build more informative angiogenesis and cancer-response experiments with Axitinib (AG 013736), from VEGFR pathway engagement to xenograft study design. The workflow separates pathway-specific inhibition from general growth arrest or cell death, improving interpretation and reproducibility.
-
GKT137831 for Reliable Redox Cell Assays
2026-09-15
This scenario-based guide explains how GKT137831, SKU B4763, can improve interpretation of viability, proliferation, and oxidative-stress assays. It connects Nox1/Nox4 inhibition with practical solvent, dosing, controls, and ferroptosis-related experimental considerations.
-
Genotyping Kit for target alleles: Workflow Guide
2026-09-14
SKU K1026 streamlines single-tube genomic DNA preparation for PCR-based allele screening across insects, tissues, fishes, and cultured cells. This guide connects practical genotyping workflows with the E-cadherin and NR1I3 findings reported in a DSS-colitis study, while emphasizing assay controls, troubleshooting, and the limits of direct-lysate PCR.
-
Nuclear cGAS, CHK2, and LINE-1 Control
2026-09-14
The reference study identifies a nuclear cGAS–CHK2–TRIM41 pathway that limits LINE-1 retrotransposition by promoting ubiquitination and degradation of the LINE-1 protein ORF2p. Its findings connect DNA damage signaling with post-translational control of mobile genetic elements, offering a mechanistic framework for genome integrity, aging, and cancer research.
-
Morin, AMPD2, and Podocyte Energy Metabolism
2026-09-13
A 2025 study identifies AMPD activity, particularly the AMPD2-linked purine nucleotide cycle, as a mechanistic driver of fructose-associated podocyte mitochondrial dysfunction. Using cellular and rat models, the authors show that Morin improves mitochondrial and glomerular injury phenotypes, while highlighting AMPD2 as a potential target for further kidney disease research.